by Brian K Carson | Jun 23, 2023 | Press Releases
info@seedtherapeutics.com info@seedtherapeutics.com PRESS RELEASES Seed Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors New York, NY – June 20, 2023 – SEED Therapeutics (the “Company”), a BeyondSpring (NASDAQ: BYSI) subsidiary...
by Brian K Carson | Jul 1, 2022 | Press Releases
info@seedtherapeutics.com info@seedtherapeutics.com PRESS RELEASES Seed Therapeutics has completed construction of a new state of the art innovation and research center at 411 Swedeland Road in King of Prussia, Pennsylvania. King of Prussia, PA – July 01, 2022...
by Andrey Alimetov | Nov 13, 2020 | Press Releases
info@seedtherapeutics.com info@seedtherapeutics.com PRESS RELEASES BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly Seed Therapeutics to Use Proprietary “Molecular Glue” Protein Degradation Technology...
by Andrey Alimetov | Oct 14, 2020 | Press Releases
info@seedtherapeutics.com info@seedtherapeutics.com PRESS RELEASES Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer “Molecular Glue” Protein Degradation Serves as Alternative Approach...
Recent Comments